Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00836329 · ClinicalTrials.gov registry record · Phase 3
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
A Phase 3 study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- Phase 3
- Development phase
- 133
- Enrollment target
NCT00836329 is a Phase 3 study that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 133 participants.
The verdict
NCT00836329, a Phase 3 study, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 133 participants
- Enrollment target
Study Summary
Preliminary studies have shown that people with diabetes who undergo heart surgery may have a higher risk of developing cognitive functioning problems, including memory problems, than people without diabetes who undergo heart surgery. Among people with diabetes, however, those who control their blood sugar levels in a more intensive way during and after heart surgery may have better neurological outcomes than those who use a standard method of controlling their blood sugar levels. This study will compare the effectiveness of using a traditional method of blood sugar control versus a more intensive method of blood sugar control during and after heart surgery for improving neurological outcomes in people with diabetes.
Interventions
- BEHAVIORAL Intensive Glucose Management
- BEHAVIORAL Traditional Glucose Management:
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2008-12 |
| Est. Completion | 2014-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00836329
The ClinicalTrials.gov registry entry for NCT00836329 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intensive Glucose Management is the first listed.
NCT00836329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00836329 about?
NCT00836329 is a clinical study titled "Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery". Preliminary studies have shown that people with diabetes who undergo heart surgery may have a higher risk of developing cognitive functioning problems, including memory problems, than people without diabetes who undergo heart surgery. Among people with diabetes, however, those who control their bloo...
What is the current status of trial NCT00836329?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 133 participants. The study started on 2008-12. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00836329?
The interventions under investigation include: Intensive Glucose Management (BEHAVIORAL), Traditional Glucose Management: (BEHAVIORAL).
Who is sponsoring clinical trial NCT00836329?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.